Showing results (51-60 of 198) with videos related to
Sort By:
Pageof 20
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 8, 2019
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing SpondylitisJoel Reis, Ron Vender, Tiago TorresThe Journal of International Medical Research|March 12, 2024
Risankizumab, a therapeutic alternative for psoriasis in people living with HIVTomás Estevinho, Egídio Freitas, Tiago TorresDrugs|October 8, 2021
Bimekizumab for the Treatment of PsoriasisEgídio Freitas, Andrew Blauvelt, Tiago TorresDrugs in Context|October 2, 2023
Efficacy and safety of baricitinib in patients with alopecia areata: evidence to dateSofia Faria, Egídio Freitas, Tiago TorresThe Journal of International Medical Research|June 13, 2023
Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?Dea Metko, Tiago Torres, Ronald VenderDrugs in Context|May 11, 2023
Deucravacitinib for the treatment of psoriatic arthritis: the evidence so farAna Martins, Ana Maria Lé, Tiago TorresGiornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 19, 2019
Dupilumab for atopic dermatitis: evidence to dateMaria A Rodrigues, Miguel Nogueira, Tiago TorresPaediatric Drugs|April 3, 2021
Targeted Therapy for Pediatric PsoriasisMiguel Nogueira, Amy S Paller, Tiago TorresClinical, Cosmetic and Investigational Dermatology|September 5, 2020
Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and RecommendationsEgídio Freitas, Maria Alexandra Rodrigues, Tiago TorresAmerican Journal of Clinical Dermatology|June 22, 2021
Tralokinumab for the Treatment of Atopic DermatitisEgídio Freitas, Emma Guttman-Yassky, Tiago TorresPageof 20